SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Uncle Frank who wrote (5998)10/14/1998 11:28:00 AM
From: Anthony Wong  Respond to of 9523
 
Pfizer Inc. Reiterated 'Strong Buy' at Gruntal
Bloomberg News
October 14, 1998, 11:06 a.m. ET

Princeton, New Jersey, Oct. 14 (Bloomberg Data) -- Pfizer Inc. (PFE US)
was reiterated ''strong buy'' by analyst David F. Saks at Gruntal & Co.
The 12-month target price is $125.00 per share.

-- Colleen Sferra in Princeton, New Jersey, (609)279-3843



To: Uncle Frank who wrote (5998)10/14/1998 11:35:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Frank, there'll be more upgrades to come, the way things are going. Is there something we don't know about, other than that the share price has already corrected quite a bit from $121?